BlackRock’s Pfizer PFE Stock Holding History

BlackRock’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$14B	Buy	498,257,550 +5,195,022	+1%	+$138M	0.24%	63
2025 Q4	$12.3B	Sell	493,062,528 -4,372,016	-0.9%	-$110M	0.21%	83
2025 Q3	$12.7B	Buy	497,434,544 +2,557,248	+0.5%	+$63.1M	0.22%	75
2025 Q2	$12B	Buy	494,877,296 +20,709,704	+4%	+$483M	0.23%	69
2025 Q1	$12B	Buy	474,167,592 +22,427,541	+5%	+$587M	0.25%	65
2024 Q4	$12B	Buy	451,740,051 +15,738,757	+4%	+$427M	0.24%	63
2024 Q3	$12.6B	Buy	436,001,294 +11,623,274	+3%	+$339M	0.26%	57
2024 Q2	$11.9B	Sell	424,378,020 -6,740,386	-2%	-$186M	0.27%	58
2024 Q1	$12B	Sell	431,118,406 -1,385,348	-0.3%	-$38.4M	0.28%	59
2023 Q4	$12.5B	Sell	432,503,754 -6,413,927	-1%	-$194M	0.32%	50
2023 Q3	$14.6B	Sell	438,917,681 -6,228,359	-1%	-$220M	0.42%	31
2023 Q2	$16.3B	Sell	445,146,040 -238,853	-0.1%	-$9.3M	0.45%	29
2023 Q1	$18.2B	Buy	445,384,893 +2,516,132	+0.6%	+$109M	0.54%	26
2022 Q4	$22.7B	Buy	442,868,761 +10,253,323	+2%	+$492M	0.71%	19
2022 Q3	$18.9B	Sell	432,615,438 -2,537,090	-0.6%	-$123M	0.64%	19
2022 Q2	$22.8B	Buy	435,152,528 +27,068,406	+7%	+$1.38B	0.73%	16
2022 Q1	$21.1B	Sell	408,084,122 -1,901,522	-0.5%	-$98.7M	0.57%	19
2021 Q4	$24.2B	Sell	409,985,644 -842,661	-0.2%	-$41.8M	0.62%	17
2021 Q3	$17.7B	Buy	410,828,305 +3,780,033	+0.9%	+$167M	0.49%	23
2021 Q2	$15.9B	Buy	407,048,272 +1,314,302	+0.3%	+$51.1M	0.44%	28
2021 Q1	$14.7B	Buy	405,733,970 +8,760,458	+2%	+$311M	0.43%	33
2020 Q4	$14.6B	Sell	396,973,512 -40,192,418	-9%	-$1.47B	0.47%	31
2020 Q3	$15.2B	Sell	437,165,930 -13,455,332	-3%	-$472M	0.56%	25
2020 Q2	$14B	Buy	450,621,262 +3,651,274	+0.8%	+$124M	0.56%	24
2020 Q1	$13.8B	Sell	446,969,988 -2,274,703	-0.5%	-$77.5M	0.68%	20
2019 Q4	$16.7B	Sell	449,244,691 -1,047,110	-0.2%	-$37.3M	0.64%	22
2019 Q3	$15.4B	Buy	450,291,801 +1,173,732	+0.3%	+$42.7M	0.64%	23
2019 Q2	$18.5B	Sell	449,118,069 -20,872,957	-4%	-$829M	0.79%	12
2019 Q1	$18.9B	Sell	469,991,026 -17,849,498	-4%	-$715M	0.85%	11
2018 Q4	$20.2B	Buy	487,840,524 +12,824,151	+3%	+$532M	1.02%	8
2018 Q3	$19.9B	Sell	475,016,373 -4,768,210	-1%	-$184M	0.86%	11
2018 Q2	$16.5B	Sell	479,784,583 -4,561,032	-0.9%	-$156M	0.76%	12
2018 Q1	$16.3B	Buy	484,345,615 +7,151,743	+1%	+$246M	0.78%	12
2017 Q4	$16.4B	Buy	477,193,872 +12,841,112	+3%	+$438M	0.78%	13
2017 Q3	$15.7B	Sell	464,352,760 -881,432	-0.2%	-$28.3M	0.79%	12
2017 Q2	$14.8B	Sell	465,234,192 -5,444,506	-1%	-$172M	0.79%	13
2017 Q1	$15.3B	Buy	470,678,698 +454,568,428	+2,822%	+$14.3B	0.84%	11
2016 Q4	$496M	Buy	16,110,270 +167,228	+1%	+$5.11M	0.7%	24
2016 Q3	$512M	Buy	15,943,042 +155,189	+1%	+$5.19M	0.74%	20
2016 Q2	$527M	Buy	15,787,853 +823,143	+6%	+$26.3M	0.79%	15
2016 Q1	$421M	Sell	14,964,710 -4,528,499	-23%	-$129M	0.68%	23
2015 Q4	$597M	Buy	19,493,209 +940,522	+5%	+$29.6M	0.88%	12
2015 Q3	$553M	Buy	18,552,687 +1,621,992	+10%	+$52M	0.87%	13
2015 Q2	$539M	Sell	16,930,695 -2,638,495	-13%	-$86M	0.8%	14
2015 Q1	$646M	Sell	19,569,190 -1,221,413	-6%	-$38.8M	0.89%	13
2014 Q4	$614M	Sell	20,790,603 -247,273	-1%	-$7.09M	0.88%	15
2014 Q3	$590M	Sell	21,037,876 -1,476,789	-7%	-$41.4M	0.86%	17
2014 Q2	$634M	Buy	22,514,665 +3,921,049	+21%	+$112M	0.94%	13
2014 Q1	$567M	Sell	18,593,616 -1,434,457	-7%	-$42.8M	0.92%	15
2013 Q4	$582M	Buy	20,028,073 +1,601,046	+9%	+$46.6M	0.95%	13
2013 Q3	$502M	Sell	18,427,027 -558,688	-3%	-$15.2M	0.95%	14
2013 Q2	$505M	Buy	+18,985,715	New	+$525M	1%	16

Other funds holding PFE

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BlackRock's PFE Position: Q1 2026 in Review

BlackRock increased its Pfizer (PFE) stake by 1.1% in Q1 2026, buying an estimated $138M and bringing the position to 498,257,550 shares worth $14B. The position accounts for 0.24% of the portfolio, ranked #63.

BlackRock first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $24.2B in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

BlackRock held 498,257,550 shares of Pfizer worth $14B as of Q1 2026.
BlackRock bought 5,195,022 Pfizer shares in Q1 2026, an estimated $138M.
Pfizer made up 0.24% of BlackRock's portfolio in Q1 2026, its #63 holding.
BlackRock first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
BlackRock's Pfizer position peaked at $24.2B in Q4 2021.
2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.